tiprankstipranks
Trending News
More News >
SynAct Pharma AB (DE:8F8)
:8F8
Germany Market

SynAct Pharma AB (8F8) Balance Sheet

Compare
0 Followers

SynAct Pharma AB Balance Sheet

SynAct Pharma AB's total assets for Q4 2024 were kr270.52M, an increase of 24.59% from the previous quarter. DE:8F8 total liabilities were kr56.35M for the fiscal quarter, a 17.48% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
kr 228.02Mkr 142.60Mkr 38.37Mkr 21.59Mkr 23.81M
Total Liabilities
kr 51.83Mkr 16.08Mkr 17.50Mkr 5.72Mkr 10.31M
Total Equity Gross Minority
kr 176.19Mkr 126.52Mkr 20.87Mkr 15.87Mkr 13.50M
Other Metrics
Currency in SEK

SynAct Pharma AB Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis